These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The glucocorticoid receptor antagonist mifepristone reduces ethanol intake in rats under limited access conditions. Koenig HN; Olive MF Psychoneuroendocrinology; 2004 Sep; 29(8):999-1003. PubMed ID: 15219650 [TBL] [Abstract][Full Text] [Related]
23. Exposure to nicotine enhances acquisition of ethanol drinking by laboratory rats in a limited access paradigm. Smith BR; Horan JT; Gaskin S; Amit Z Psychopharmacology (Berl); 1999 Mar; 142(4):408-12. PubMed ID: 10229066 [TBL] [Abstract][Full Text] [Related]
24. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone. Myers RD; Lankford MF Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536 [TBL] [Abstract][Full Text] [Related]
25. Ethanol intake is increased by injection of galanin in the paraventricular nucleus and reduced by a galanin antagonist. Rada P; Avena NM; Leibowitz SF; Hoebel BG Alcohol; 2004 Jun; 33(2):91-7. PubMed ID: 15528006 [TBL] [Abstract][Full Text] [Related]
26. Saccharin consumption and the effect of a long-term exposure to a sweetened alcoholic solution in high- (UChB) and low- (UChA) alcohol-drinking rats. Tampier L; Quintanilla ME Alcohol; 2005 Aug; 37(1):47-52. PubMed ID: 16472718 [TBL] [Abstract][Full Text] [Related]
27. Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Overstreet DH; Lee YW; Rezvani AH; Pei YH; Criswell HE; Janowsky DS Alcohol Clin Exp Res; 1996 Apr; 20(2):221-7. PubMed ID: 8730211 [TBL] [Abstract][Full Text] [Related]
29. Dissociation of ethanol and saccharin preference in sP and sNP rats. Agabio R; Carai MA; Lobina C; Pani M; Reali R; Bourov I; Gessa GL; Colombo G Alcohol Clin Exp Res; 2000 Jan; 24(1):24-9. PubMed ID: 10656188 [TBL] [Abstract][Full Text] [Related]
30. Heart rate and motor-activating effects of orally self-administered ethanol in alcohol-preferring (P) rats. Bell RL; Rodd-Henricks ZA; Webster AA; Lumeng L; Li TK; McBride WJ; Murphy JM Alcohol Clin Exp Res; 2002 Aug; 26(8):1162-70. PubMed ID: 12198390 [TBL] [Abstract][Full Text] [Related]
31. Repeated exposure to alcoholic beer does not induce long-lasting changes in alcohol self-administration and intake in Sardinian alcohol-preferring and Sardinian non-preferring rats. Orrù A; Lobina C; Maccioni P; Gessa GL; Carai MA; Colombo G Alcohol Alcohol; 2007; 42(6):513-24. PubMed ID: 17878214 [TBL] [Abstract][Full Text] [Related]
32. Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats. Murphy JM; Gatto GJ; Waller MB; McBride WJ; Lumeng L; Li TK Alcohol; 1986; 3(5):331-6. PubMed ID: 3778650 [TBL] [Abstract][Full Text] [Related]
33. Changes in drinking behaviour and cholinergic binding sites induced by intermittent long-term ethanol treatment in the male rat. Wahlström G; Nordberg A Alcohol Alcohol; 1991; 26(5-6):575-84. PubMed ID: 1804137 [TBL] [Abstract][Full Text] [Related]
34. Chronic ethanol tolerance through free-choice drinking in the P line of alcohol-preferring rats. Gatto GJ; Murphy JM; Waller MB; McBride WJ; Lumeng L; Li TK Pharmacol Biochem Behav; 1987 Sep; 28(1):111-5. PubMed ID: 3659102 [TBL] [Abstract][Full Text] [Related]
35. Effects of fluoxetine and desipramine on palatability-induced ethanol consumption in the alcohol-nonpreferring (NP) line of rats. Gatto GJ; Murphy JM; McBride WJ; Lumeng L; Li TK Alcohol; 1990; 7(6):531-6. PubMed ID: 2261092 [TBL] [Abstract][Full Text] [Related]
36. Blood alcohol concentrations after scheduled access in high-alcohol-preferring mice. Grahame NJ; Grose AM Alcohol; 2003; 31(1-2):99-104. PubMed ID: 14615017 [TBL] [Abstract][Full Text] [Related]
37. The role of nicotinic receptors in alcohol consumption. Kamens HM; Flarend G; Horton WJ Pharmacol Res; 2023 Apr; 190():106705. PubMed ID: 36813094 [TBL] [Abstract][Full Text] [Related]
38. Cholinergic and dopaminergic-mediated motivated behavior in healthy states and in substance use and mood disorders. Nunes EJ; Kebede N; Bagdas D; Addy NA J Exp Anal Behav; 2022 May; 117(3):404-419. PubMed ID: 35286712 [TBL] [Abstract][Full Text] [Related]
39. Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey. McKee SA; Young-Wolff KC; Harrison EL; Cummings KM; Borland R; Kahler CW; Fong GT; Hyland A Alcohol Clin Exp Res; 2013 May; 37(5):804-10. PubMed ID: 23240586 [TBL] [Abstract][Full Text] [Related]
40. Development of an oral operant nicotine/ethanol co-use model in alcohol-preferring (p) rats. Hauser SR; Katner SN; Deehan GA; Ding ZM; Toalston JE; Scott BJ; Bell RL; McBride WJ; Rodd ZA Alcohol Clin Exp Res; 2012 Nov; 36(11):1963-72. PubMed ID: 22486609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]